Godavari Drugs Ltd. (GODAVARI): Godavari Drugs Share Price Rises 10.83% Today

Published: 25 September 2026 at 9:49:53 AM IST

Godavari Drugs Share Price moved to Rs 121.77 today, up 10.83% from the previous close of Rs 109.87, with market capitalisation at Rs 119.91 crore. The stock opened at Rs 111.50, touched an intraday high of Rs 123 and a low of Rs 111.50, and finished well above the prior close. Godavari Drugs Ltd. is therefore among the stocks in news today, even though the supplied data does not establish a company-specific catalyst for the move. For readers tracking Godavari Drugs Share Price Today, the key takeaway is straightforward: the rise is verified, the session range is defined, and the financial context can now be read alongside valuation and sector benchmarks.

This update is best read as a price-led market note rather than a story about a fresh operating development. The available information confirms where the stock opened, where it traded during the day, and how strongly it outperformed the previous close. It also shows that the move occurred in a small-cap style market context, where price changes can draw attention quickly when they occur alongside a relatively modest market capitalisation. At Univest, we keep the focus on the numbers that are actually supplied, so this article stays grounded in verified price action and comparable fundamentals.

Godavari Drugs Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 121.77
Previous Close	Rs 109.87
Today's Move	Rs 11.9 (+10.83%)
Open	Rs 111.5
High	Rs 123
Low	Rs 111.5
Turnover	Rs 0.09 crore
Market Capitalisation	Rs 119.91 crore
Market Cap Category	Micro Cap

Godavari Drugs Ltd. (GODAVARI) rose to Rs 121.77 from the previous close of Rs 109.87, a move of Rs 11.9 or 10.83%. The stock opened at Rs 111.5, reached a high of Rs 123, recorded a low of Rs 111.5.

Godavari Drugs Ltd. (GODAVARI) rose to Rs 121.77 from the previous close of Rs 109.87, a move of Rs 11.9 or 10.83%. The stock opened at Rs 111.5, reached a high of Rs 123, and recorded a low of Rs 111.5. That means the day began at the lower end of the range and later advanced enough to finish near the session high, which is consistent with a firm intraday recovery and a strong close relative to the prior day.

The shape of the session matters as much as the percentage change. Opening at Rs 111.50 placed the stock only modestly above the previous close, but the movement up to Rs 123.00 shows that buyers were able to push the price materially higher during the day. Because the low also matched the open, the entire move happened above the day’s starting point rather than after an early downside break. For readers scanning Godavari Drugs Share Price news, that makes the session noteworthy even without a disclosed trigger.

Turnover stood at Rs 0.09 crore, which is a useful context point for this update but should be read carefully alongside the company’s micro-cap status. In smaller companies, even a well-defined price rise can occur without a broad market narrative being visible in the supplied data. What the figures do confirm is that the stock did not merely drift higher; it posted a clear and measurable jump from the prior close and held most of that gain into the session’s end. That is why Godavari Drugs Share Price Today is drawing attention.

For investors following Godavari Drugs Share Price Live, the important observation is the combination of a double-digit gain and a close that stayed close to the upper end of the day range. The move to Rs 121.77 also means the stock ended above the day’s opening price by a clear margin. In practical terms, the market showed willingness to revalue the stock upward during the session, even though the supplied dataset does not identify the catalyst behind that shift.

It is also worth separating the price action from the interpretation. The numbers show strength, but they do not tell us whether the move was driven by earnings, order flow, sentiment or any other specific event. Because the dataset does not support a cause, the most disciplined reading is to treat this as a confirmed price rise and to evaluate the company’s valuation and peer standing next. That keeps the Godavari Drugs Share Price discussion factual and avoids adding speculation.

Godavari Drugs Ltd. (GODAVARI) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 119.91 crore
P/E Ratio	28.85x
P/B Ratio	1.52x
ROE	10.64%
ROCE	10.13%
EPS	Rs 3.81
Book Value Per Share	Rs 72.07
Dividend Yield	0%

Godavari Drugs Ltd. (GODAVARI) fundamental metrics show P/E 28.85x, P/B 1.52x, ROE 10.64%, ROCE 10.13%. These figures provide context only and are not a buy or sell signal.

Godavari Drugs Ltd. has a market capitalisation of Rs 119.91 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 28.85x, P/B at 1.52x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 10.64% and ROCE of 10.13%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 3.81, book value per share of Rs 72.07, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.73x, median ROE of 11.7%, median ROCE of 13.61%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	28.85x
Benchmark Median P/E	32.73x
Benchmark Average P/E	49.58x
Benchmark P/E Range	3.48x to 757.76x
Company P/B Ratio	1.52x
Benchmark Median P/B	2.95x
Company ROE	10.64%
Benchmark Median ROE	11.7%
Company ROCE	10.13%
Benchmark Median ROCE	13.61%
Company Market Capitalisation	Rs 119.91 crore
Benchmark Median Market Cap	Rs 804.62 crore

Godavari Drugs Ltd. (GODAVARI) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Godavari Drugs Ltd. (GODAVARI) has a P/E ratio of 28.85x, which is below the benchmark median of 32.73x, a difference of -11.85%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Godavari Drugs Ltd. (GODAVARI) has a ROE of 10.64%, which is below the benchmark median of 11.7%, a difference of -9.06%. Godavari Drugs Ltd. (GODAVARI) has a ROCE of 10.13%, which is below the benchmark median of 13.61%, a difference of -25.57%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,47,475.97	36.76	5.14	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,54,763.56	87.25	14.45	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,89,423.19	86.07	20.91	26.76	19.27
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,16,658.07	26.08	4.37	19.69	21.39
Cipla Ltd.	CIPLA	1,11,484.47	33.65	3.23	11.83	16

Godavari Drugs Ltd. (GODAVARI) has a P/E ratio of 28.85x compared with the displayed peer median of 36.76x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 10.64% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 10.13% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Godavari Drugs Ltd. (GODAVARI) has a market capitalisation of Rs 119.91 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Godavari Drugs

• Godavari Drugs Share Price rose 10.83% today to Rs 121.77.
• The stock moved from a previous close of Rs 109.87 to an intraday high of Rs 123.00.
• Market capitalisation stood at Rs 119.91 crore.
• P/E is 28.85, P/B is 1.52, ROE is 10.64% and ROCE is 10.13%.
• Sector comparison shows the company below the industry median on P/E, P/B, ROE and ROCE.

About Godavari Drugs

Godavari Drugs Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied company data identifies the sector and industry, which places the business within a regulated pharmaceutical operating environment. From the market data provided, the company’s share price behaviour can be viewed alongside earnings, book value and return ratios rather than as a standalone trading move. Godavari Drugs Share Price is therefore relevant not only because it rose today, but also because investors can place the move against the company’s financial profile and the wider pharmaceutical benchmark. Univest keeps this company view concise and factual: what the business belongs to, how it is classified, and how its share price fits into the broader market update.

That context matters because healthcare stocks are often compared with peers on valuation and capital efficiency, not just on day-to-day price swings. In this case, the available numbers point to a small company with a modest market capitalisation and a valuation that sits below the benchmark median on both P/E and P/B. Those facts do not explain the rise, but they do help frame it. For readers looking at Godavari Drugs Share Price Today, the most useful reading is to combine the price move with the company’s size, earnings base and profitability ratios.

Track Godavari Drugs Share Price on Univest for live share price updates, valuation ratios, shareholding pattern, 52-week levels and market insights. Univest also helps users follow Godavari Drugs Stock News, Godavari Drugs Latest News and Godavari Drugs Fundamental Analysis in one place. For readers comparing healthcare names, Univest makes it easier to review Godavari Drugs Share Price Today alongside company metrics, sector context and peer data as new market updates appear.

Frequently Asked Questions

Why did Godavari Drugs Share Price rise today?

Ans. The supplied data confirms a 10.83% rise in Godavari Drugs Share Price, but it does not identify a specific corporate event or announcement as the reason. The article should therefore be read as a verified price update, not a catalyst-led.

What is Godavari Drugs Share Price today?

Ans. Godavari Drugs Share Price today is Rs 121.77. It rose by Rs 11.90 from the previous close of Rs 109.87, and the session reached an intraday high of Rs 123.00 before ending near that range.

What is Godavari Drugs market cap?

Ans. Godavari Drugs has a market capitalisation of Rs 119.91 crore. Within the supplied Pharmaceuticals & Drugs benchmark, that places the company well below the industry median market cap and within a smaller size bracket than several listed peers.

How does Godavari Drugs compare with healthcare peers?

Ans. Godavari Drugs Share Price is supported by a much smaller market cap than the peer names shown, including Sun Pharma, Divi's Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences and Cipla. Its P/E and P/B are also lower than several of those peers.

What are Godavari Drugs ROE and ROCE?

Ans. Godavari Drugs reports ROE of 10.64% and ROCE of 10.13%. Both figures are useful for context because they show the company’s return profile, but they remain below the benchmark medians supplied for the same industry comparison set.